NCT01746719View on ClinicalTrials.gov

Bioequivalence Study of Etodolac Capsules USP 300 mg Under Fasting Condition

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Fasting
Interventions
DRUG

Etodolac Capsules USP 300 mg

300 mg capsule once a day

DRUG

Etodolac

500 mg tablet once a day

Trial Locations (1)

Unknown

Veeda Clinical Research Pvt. Ltd., Ahmedabad

Sponsors
All Listed Sponsors
lead

IPCA Laboratories Ltd.

INDUSTRY